06torrentlogo1
Darifenacin Tablet, Extended Release
Product Images NDC 13668-202
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Darifenacin (NDC 13668-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
07torrentlogo2
15 mg 30 Ct Bottle Label
This is a description of a medication called Darifenacin. Each tablet contains 17.860 mg of darifenacin hydrobromide (equivalent to 15 mg darfenacin) and should be stored at 20-25°C. The tablets should be swallowed whole and dispensed in a child-resistant container. The dosage should be determined by the prescribing information. The medication is manufactured by Torrent Pharmaceuticals LTD in India and should only be sold with a prescription.*
75 mg 30 Ct Bottle Label
This is a description of a medication called Darifenacin. It is available in extended-release tablets of 30 tablets with the strength of 83500 conrs and a product code of NG 13668-202-30. However, the remaining text seems to be jumbled and does not make sense, so further information cannot be inferred.*
Figure 2a Study 1
Figure 2b, Study 2
Figure 2c, Study 3
Figure 1
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
